Day: February 4, 2021

Suominen Corporation’s stock exchange release on February 4, 2021 at 9:15 a.m. EETThe Board of Directors of Suominen Corporation has resolved on February 3, 2021 on a new share-based Long-Term Incentive Plan for the management and key employees. The aim of the new plan is to combine the objectives of the shareholders and the persons participating in the plan in order to increase the value of the Company in the long-term, to bind the participants to the Company, and to offer them competitive reward plans based on earning and accumulating the Company’s shares.Performance Share Plan 2021–2023The new long-term Performance Share Plan has one three-year Performance Period, which includes calendar years 2021–2023. The Performance Share Plan is directed to approximately 20 people including the President & CEO of Suominen.The Board...

Suominen Oyj:n pörssitiedote 4. helmikuuta 2021 klo 9.15Suominen Oyj:n hallitus on kokouksessaan 3.2.2021 hyväksynyt yrityksen johdolle ja avainhenkilöille uuden osakepohjaisen pitkän aikavälin kannustinjärjestelmän. Uuden kannustinjärjestelmän tavoitteena on yhdistää osakkeenomistajien sekä johdon ja avainhenkilöiden tavoitteet yhtiön arvon lisäämiseksi pitkällä aikavälillä, sitouttaa osallistujat yhtiöön ja tarjota heille kilpailukykyinen, yhtiön osakkeiden ansaitsemiseen ja kerryttämiseen perustuva palkkiojärjestelmä.Suoriteperusteinen osakepalkkiojärjestelmä 2021–2023Uudessa osakepalkkiojärjestelmässä on yksi kolmivuotinen ansaintajakso, joka kattaa kalenterivuodet 2021–2023. Osakepalkkiojärjestelmän piirissä on noin 20 henkilöä mukaan lukien Suomisen toimitusjohtaja.Hallitus on päättänyt, että ansaintajakson 2021–2023 perusteella...

Press release – Paris, February 4, 2021Implementation of a share buyback programAt its meeting on December 17, 2020, the board of Directors of SMCP decided, in accordance with the 18th resolution approved by the Shareholders’ Meeting on June 4, 2020, to authorize the Group to implement a share buyback program.In accordance with this authorization, a mandate was granted to an investment services provider to purchase from February 4, 2021 and for a period ending on April 2, 2021 a maximum of 415 000 shares (corresponding to 0.55% of SMCP’s share capital) for a purchase price that cannot exceed the maximum price set by the 18th resolution.The purpose of the share buyback program is to cover its long-term incentive programs (LTIP), as was the case for the first share buyback program carried out in the second half of 2019.ABOUT SMCPSMCP...

Communiqué de presse – Paris, le 4 février 2021Mise en œuvre d’un programme de rachat d’actionsLe conseil d’administration de SMCP, réuni le 17 décembre 2020, a décidé, en application de la 18ème résolution de l’assemblée générale mixte du 4 juin 2020, d’autoriser le Groupe à mettre en œuvre un programme de rachat de ses propres actions.En application de cette autorisation, un mandat a été confié à un prestataire de services d’investissement afin de procéder à des achats d’actions de la société SMCP SA à partir du 4 février 2021 et pour une période allant jusqu’au 2 avril 2021 pour un volume maximum de 415 000 titres (correspondant à 0,55% du capital de SMCP) à un prix qui ne pourra pas excéder le prix maximum fixé par la 18ème résolution.Le programme de rachat d’actions est destiné à couvrir son plan d’attribution d’actions gratuites...

DXS INTERNATIONAL PLC(AQSE: DXSP)Update on Hypertension Pilot ProgrammeDXS International plc (“DXS”, the “Company”), the digital clinical decision support Company, is pleased to update shareholders on its ExpertCare hypertension solution pilot programme.Managing patients on medication for hypertension is complex, exacerbated by the fact that more than 60% of hypertensives have one or more comorbidity such as Diabetes, Atrial Fibrillation, or COPD. While UK guidelines on how to treat this exist, getting the medicines combination and dosages correct for all hypertensive patients is extremely difficult for busy clinicians.DXS has invested five years and over £1.5 million creating ExpertCare which is able to analyse and interpret a patient’s electronic record and instantly present prescribing recommendations. There are...

Electromagnetic Geoservices ASA’s (“EMGS” or the “Company”) financial report and market presentation for the fourth quarter of 2020 are attached. Highlights: * The Company recorded revenues of USD 4.0 million, down from USD 37.2 million in the fourth quarter of 2019 and up from USD 2.1 million in the third quarter of 2020. * As of 2 February 2021, USD 7.3 million held in a pledge account has been released and is now moved from restricted cash to cash and cash equivalents.  EMGS expect, upon reaching certain conditions, to issue a time-limited guarantee, secured by cash in a pledged account, in the amount of approximately USD 3.6 million. * Subsequent to the end of the fourth quarter 2020, EMGS received payment in the amount of USD 3.9 million related to significantly past due receivables totalling USD 5.0 million as of 31 December 2020.  Correction:...

Kinnevik AB (publ) (“Kinnevik”) today announced that Senior Investment Director Chris Bischoff has decided to leave Kinnevik to take up a role as a Managing Director at General Catalyst. Chris will continue to represent Kinnevik on selected company boards.Chris Bischoff joined Kinnevik in 2013 and during his time with Kinnevik has focused on the international investment activities, including leading the investments within Kinnevik’s successful healthcare portfolio, supported the formation of a strong sector focused investment team and leading the London office. Chris will leave Kinnevik during the second quarter, but he will continue to represent Kinnevik on selected company boards. Kinnevik has partnered with General Catalyst on multiples investments including Livongo and Cityblock and will continue to seek out opportunities to...

Kinnevik AB (publ) (“Kinnevik”) meddelade idag att bolagets Senior Investment Director Chris Bischoff kommer att lämna Kinnevik för en roll som Managing Director på General Catalyst. Chris kommer att fortsätta att representera Kinnevik i ett antal utvalda bolagsstyrelser.Chris Bischoff började på Kinnevik 2013 och har under sin tid på Kinnevik fokuserat på internationella investeringar. Han har bland annat lett investeringarna inom vår framgångsrika portfölj av hälsovårdsbolag, varit del i att bygga upp ett starkt sektorfokuserat investeringsteam och varit ansvarig för Londonkontoret. Chris kommer att lämna Kinnevik under andra kvartalet, men fortsätta att representera Kinnevik i ett antal utvalda bolagsstyrelser. Kinnevik har samarbetat med General Catalyst i ett antal investeringar, inklusive Livongo och Cityblock, och kommer...